medi-557
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2007 (NCT00578682)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Fusion glycoprotein F0INHIBITOR
F inhibitor
- RSV F-proteinImmunity, passive
RSV F-protein immunity, passive
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109566 ↗
Also known as
- medi-557
- medi-557
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01562938 | Phase 1 | Mar 1, 2012 | MedImmune |
| NCT01475305 | Phase 1 | Nov 1, 2011 | MedImmune |
| NCT00578682 | Phase 1 | Dec 1, 2007 | MedImmune |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MedImmune | For profit | 3 | 3 | 1 | 2007 |
1 organizations
Page 1 / 1